Skip to main content
Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
6.08
+0.17 (2.88%)
At close: Nov 13, 2026, 4:00 PM EST
6.11
+0.03 (0.49%)
After-hours: Nov 13, 2026, 7:30 PM EST

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics had revenue of $2.53M in the twelve months ending September 30, 2026, down -51.28% year-over-year. In the year 2025, Bolt Biotherapeutics had annual revenue of $7.70M with 0.07% growth. That makes Bolt Biotherapeutics the 40,172nd largest company in the world by revenue and 5,331st in the United States.

Revenue (ttm)
$2.53M
Revenue Growth
-51.28%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
23
Market Cap
11.95M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.70M5.00K0.07%
Dec 31, 20247.69M-186.00K-2.36%
Dec 31, 20237.88M2.15M37.48%
Dec 31, 20225.73M4.47M354.68%
Dec 31, 20211.26M1.03M445.45%
Dec 31, 2020231.00K16.00K7.44%
Dec 31, 2019215.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

BOLT News

More News